Balchem Q4 record net sales $240M, adjusted EBITDA $62.8M, EPS $1.03

BALCHEM CORP

2024-FY EPS reported $3.93 revenue$953,684,000

Q4 net sales record $240.0M (+4.9% YoY); GAAP EPS $1.03 vs $0.82; adjusted EPS $1.13 vs $0.95.
Q4 adjusted EBITDA record $62.8M (+13.4%); free cash flow $39.8M.
Full-year record net sales $953.7M (+3.4%); GAAP EPS $3.93 vs $3.35; adjusted EPS $4.37 vs $4.00.
Full-year adjusted EBITDA record $250.3M (+8.4%); operating cash flow $182.0M.
Dividend increased double-digits; debt reduced by $119.6M in FY2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.